PALO ALTO, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. announced today that Kathryn E. Falberg has been appointed Senior Vice President and Chief Financial Officer. Ms. Falberg brings to Jazz Pharmaceuticals more than 20 years of financial officer and director experience. As Jazz Pharmaceutical’s CFO, Ms. Falberg will be responsible for the Company’s accounting, corporate finance, financial planning, investor relations, and treasury functions.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc.
